Evidence map›Paper›PMID 32309633›Full record

ArticleACS biomaterials science & engineering2017

Controlled release of nitric oxide from liposomes.

Dakota J Suchyta, Mark H Schoenfisch

Open access · greenAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  4. Article
  5. Advances of medical nanorobots for future cancer treatments.Journal of hematology & oncology · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Preparation, Characterization, andInternational journal of nanomedicine · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Controlled Delivery of Nitric Oxide for Cancer Therapy.Pharmaceutical nanotechnology · 2019
    Review
  15. Review
  16. Progress and Promise of Nitric Oxide-Releasing Platforms.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dakota J SuchytaDepartment of Chemistry, The University of North Carolina at Chapel Hill, 131 South Rd., Chapel Hill, North Carolina, 27599.
Mark H SchoenfischDepartment of Chemistry, The University of North Carolina at Chapel Hill, 131 South Rd., Chapel Hill, North Carolina, 27599.
University of North Carolina at Chapel Hill · US

Funding

Nitric oxide-releasing dendrimers for the treatment of periodontal diseaseR01DE025207 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SCHOENFISCH, MARK H · 2015 to 2019
$1.6M
NIDCR NIH HHS R01 DE025207
6 · The paper itself

Abstract

We report the ability to readily tune NO release from

Indexed as

bloodcontrolled-releasedrug deliveryLiposomenitric oxideserum

Identifiers

PMID32309633
PMCPMC7164781
OpenAlexW2728476182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.